An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

HIV is currently the only disease carrying a felony charge if someone knowingly transmits it to another person. The Senate ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...